Canada markets closed

NervGen Pharma Corp. (NGEN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
2.1600+0.1100 (+5.37%)
At close: 03:59PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-18,929
-22,382
-20,722
-12,727
-11,186
Depreciation & amortization
91.566
145.002
115.114
42.626
39.645
Stock based compensation
3,314
6,045
2,775
4,016
3,415
Change in working capital
1,238
-240.348
2,115
430.499
1,417
Accounts receivable
15.465
-223.182
36.975
-1.408
59.908
Accounts Payable
-
-
2,320
318.734
-165.083
Other working capital
-15,608
-11,437
-17,805
-8,314
-6,301
Other non-cash items
14.661
14.661
528.9
-
-
Net cash provided by operating activites
-15,587
-11,296
-17,784
-8,269
-6,298
Cash flows from investing activities
Investments in property, plant and equipment
-21.104
-141.403
-21.105
-45.085
-3.421
Net cash used for investing activites
-21.104
-138.854
-21.105
-45.085
-3.421
Cash flows from financing activities
Debt repayment
-100.926
-100.926
-75.695
0
-
Common stock issued
31,305
0
19,763
18,902
8,709
Other financing activites
-1,099
-
-129.042
-1,666
-1,169
Net cash used privided by (used for) financing activities
34,150
766.285
22,641
19,613
7,849
Net change in cash
19,450
-10,792
5,523
11,330
1,502
Cash at beginning of period
8,249
22,452
16,929
5,599
4,106
Cash at end of period
26,791
11,660
22,452
16,929
5,608
Free Cash Flow
Operating Cash Flow
-15,587
-11,296
-17,784
-8,269
-6,298
Capital Expenditure
-21.104
-141.403
-21.105
-45.085
-3.421
Free Cash Flow
-15,608
-11,437
-17,805
-8,314
-6,301